Completed
Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors
NCT03583086
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Providence Cancer Institute Franz Clinic Portland, Oregon, United States